Drug Discovery & Pharmaceuticals

RSS

Beijing Tide Pharmaceutical and Insilico Medicine announce cancer drug discovery collaboration

Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited, and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines, announced today that they are entering a collaboration, applying artificial intelligence technology to drug discovery, to jointly accelerate the process for multiple types of cancer treatment.

16 Mar 2020

Single-drug therapy can attack several cellular targets using different modes of action

Clinicians combat the drug resistances of some cancer types by using a combination of different drugs. To make this approach more effective, chemists have designed a chemical conjugate that can simultaneously attack several cellular targets using different modes of action.

13 Mar 2020

'Virtual screening' identifies active substances with potential to combat coronavirus

The University of Basel is part of the global search for a drug to fight the rampant coronavirus. Researchers in the Computational Pharmacy group have so far virtually tested almost 700 million substances, targeting a specific site on the virus - with the aim of inhibiting its multiplication.

11 Mar 2020

Study uncovers novel relationships between SLCs and cytotoxic drugs in human cells

Solute carriers represent the largest family of transmembrane transporters in the human genome, with over 400 members arranged into 65 families.

9 Mar 2020

New route for total synthesis of tetrodotoxin

In Japan, puffer fish is considered a delicacy, but the tickle to the taste buds comes with a tickle to the nerves: fugu contains tetrodotoxin, a strong nerve toxin.

6 Mar 2020

SFU researchers help discover potential new drug to kill superbugs

Researchers in Simon Fraser University's Brinkman Laboratory are collaborating with U.S. researchers to test a new drug that can kill a wide range of superbugs - including some bacteria now resistant to all common antibiotics.

3 Mar 2020

New tool shows potential to predict developmental toxicity in humans with high accuracy

Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc. demonstrated the platform's ability to predict developmental toxicity in humans with high accuracy using a cell-based test.

3 Mar 2020

WFIRM scientists develop miniature organ model to test drug toxicity

Scientists at the Wake Forest Institute for Regenerative Medicinehave developed the world's most sophisticated laboratory model of the human body, creating a system of miniaturized organs that can be used to detect harmful and adverse effects of drugs before they are prescribed to patients.

2 Mar 2020

Researchers develop multi-organ-on-a-chip for drug toxicity screening

Researchers in the US have developed a new multi-organ-on-a-chip to test how new drugs affect the human body's vital organs.

2 Mar 2020

Boehringer Ingelheim and Trutino enter into research collaboration to advance cytokine therapies

Boehringer Ingelheim and Trutino Biosciences today announced they have entered into a research collaboration and worldwide licensing agreement based on Trutino’s innovative On-Demand-Cytokine platform.

From Boehringer Ingelheim International GmbH 28 Feb 2020

McMaster researchers identify antibacterial compound made by cannabis plants

McMaster University researchers have identified an antibacterial compound made by cannabis plants that may serve as a lead for new drug development.

26 Feb 2020

CQDM and GlycoNet collaborate to support innovative glycomics research in Canada

CQDM and the Canadian Glycomics Network (GlycoNet) are pleased to announce they have formed a strategic partnership to identify and co-finance biopharmaceutical research projects in glycoscience across Canada.

25 Feb 2020

Essential oil components could meet the criteria set for drug candidates

A research team at the VIB-KU Leuven Center for Microbiology and the KU Leuven Department of Biology showed that, contrary to generally held belief, most components of essential oils could meet the criteria set for drug candidates.

23 Feb 2020

Catalytic nanoreactors could simplify the manufacturing process of fine chemicals

The World Health Organization declared the novel coronavirus outbreak a 'Public Health Emergency of International Concern' on the 30th of January

22 Feb 2020

Isolating Single T-cells of Interest using an Optofluidic Platform

Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.

From Bruker Cellular Analysis 21 Feb 2020

Active droplets for precise dosing of medication

Using a mixture of oil droplets and hydrogel, medical active agents can be not only precisely dosed, but also continuously administered over periods of up to several days. The active agents inside the droplets are released at a constant rate, decreasing the risk of over- or underdosage.

20 Feb 2020

Drug Discovery & Pharmaceuticals

Beijing Tide Pharmaceutical and Insilico Medicine announce cancer drug discovery collaboration

Single-drug therapy can attack several cellular targets using different modes of action

'Virtual screening' identifies active substances with potential to combat coronavirus

Study uncovers novel relationships between SLCs and cytotoxic drugs in human cells

New route for total synthesis of tetrodotoxin

SFU researchers help discover potential new drug to kill superbugs

New tool shows potential to predict developmental toxicity in humans with high accuracy

WFIRM scientists develop miniature organ model to test drug toxicity

Researchers develop multi-organ-on-a-chip for drug toxicity screening

Boehringer Ingelheim and Trutino enter into research collaboration to advance cytokine therapies

McMaster researchers identify antibacterial compound made by cannabis plants

CQDM and GlycoNet collaborate to support innovative glycomics research in Canada

Essential oil components could meet the criteria set for drug candidates

Catalytic nanoreactors could simplify the manufacturing process of fine chemicals

Isolating Single T-cells of Interest using an Optofluidic Platform

Active droplets for precise dosing of medication

StemBioSys announces acquisition of majority stake in Cartox

SwRI's Rhodium evaluates drug compounds for possible treatment of coronavirus

UPM joins Finnish research consortium to advance extracellular vesicle technologies

DuPont Nutrition & Biosciences partners with microbiome specialist MRM Health

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest Life Science News